Sanofi, established in 2004 through the merger of Sanofi-Synthélabo and Aventis, has since become one of the largest pharmaceutical companies globally. Sanofi operates across multiple therapeutic areas, including diabetes, cardiovascular diseases, vaccines, oncology, immunology, and rare diseases.
The company's focus extends from research and development to manufacturing and marketing a wide range of pharmaceutical products, including prescription drugs, over-the-counter medications, and vaccines. With a presence in both developed and emerging markets, Sanofi is committed to addressing global health challenges and improving access to healthcare worldwide.
Sanofi has a significant presence in the United States, with operations spanning research, development, manufacturing, and marketing of pharmaceutical products throughout the country.